Coppell Advisory Solutions’s Boston Scientific BSX Stock Holding History

Coppell Advisory Solutions’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-1,080	Closed	-$96.9K	–	528
2024 Q4	$96.9K	Sell	1,080 -110	-9%	-$9.68K	0.01%	422
2024 Q3	$99.2K	Buy	1,190 +162	+16%	+$12.8K	0.01%	398
2024 Q2	$79.2K	Buy	+1,028	New	+$75.2K	0.01%	405
2023 Q4	$25K	Sell	433 -567	-57%	-$30.3K	0.01%	666
2023 Q3	$46.3K	Buy	1,000 +367	+58%	+$19.2K	0.02%	329
2023 Q2	$33.7K	Buy	+633	New	+$33.1K	0.01%	462
2023 Q1	–	Sell	-1,000	Closed	-$46.3K	–	312
2022 Q4	$46.3K	Buy	+1,000	New	+$43.3K	0.02%	332

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Coppell Advisory Solutions's BSX Position: Q1 2025 in Review

Coppell Advisory Solutions sold out of Boston Scientific (BSX) in Q1 2025, closing a stake of 1,080 shares — an estimated $96.9K sold.

Coppell Advisory Solutions first reported a position in BSX in Q4 2022 and held it in 7 quarters. The position peaked at $99.2K in Q3 2024. 1,642 funds tracked by Wall St. Rank hold BSX as of Q1 2025.

Coppell Advisory Solutions reported no remaining Boston Scientific position as of Q1 2025 after selling out during the quarter.
Coppell Advisory Solutions sold 1,080 Boston Scientific shares in Q1 2025, an estimated $96.9K.
Coppell Advisory Solutions first reported a position in Boston Scientific in Q4 2022 and held it in 7 quarters.
Coppell Advisory Solutions's Boston Scientific position peaked at $99.2K in Q3 2024.
1,642 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2025.

Based on Coppell Advisory Solutions's 13F filing for Q1 2025, filed 16 May 2025.